Personalized prevention and population health impact: How can public health professionals be more engaged? by Boccia, S. (ORCID:0000-0002-1864-749X) & Ricciardi, W. (ORCID:0000-0002-5655-688X)
2 Rechel B, editor. Organization and Financing of Public Health Services in
Europe: Country Reports. Copenhagen: World Health Organization (29 June 2018,
date last accessed).
3 World Health Organization. The Ottawa Charter for Health Promotion. Geneva,
Switzerland: WHO; 1986. Available at: http://www.who.int/healthpromotion/
conferences/previous/ottawa/en/index.html
4 McKee M, Stuckler D, Zeegers Paget D, Dorner T. The Vienna declaration on public
health. Eur J Public Health 2016;26:897–8.
5 World Health Organization. European Action plan for Strengthening Public Health
Capacities and Services. Copenhagen: Regional Committee for Europe. Available at:
http://www.euro.who.int/en/health-topics/Health-systems/public-health-services/
publications/2012/european-action-plan-for-strengthening-public-health-capaci-
ties-and-services (28 April 2020, date last accessed).
6 Kluge H. A new vision for WHO’s European Region: united action for better health.
Lancet Public Health 2020;5:e133–4.
...........................................................................................................................................................................................................................
The European Journal of Public Health, Vol. 30, No. 3, 392–393
 The Author(s) 2020. Published by Oxford University Press on behalf of the European Public Health Association.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/),
which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
doi:10.1093/eurpub/ckaa018
.........................................................................................................................................
Personalized prevention and population health impact:
how can public health professionals be more engaged?
Stefania Boccia1,2, Walter Ricciardi1,2
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ince 2000 incredible advancement in genotyping technology,
coupled with the reduction in the costs of genome sequencing
and the more recent advent of digital technologies in healthcare
including wearable devices and mHealth, initiated a third revolution
in medicine. Such technologies are creating unprecedented oppor-
tunities for disease prevention, diagnosis and treatment and for dis-
ease monitoring on a personalized basis, both within the health
system and beyond. As all the new technologies and their applica-
tions advance, they are likely to play an integral role in shaping
healthcare and the ways in which citizens manage and optimize their
health.1
While we acknowledge that preventive activities in healthcare
represent a key pillar for guarantee health system sustainability,
such innovative in diseases’ prevention are not yet fulfilled. As high-
lighted by the European Steering Group on Sustainable Healthcare
and more recently reaffirmed in the State of the Health of EU of the
Companion report2, the implementation of sustainable healthcare
requires a shift from treatment of established disease, to disease
prevention and early diagnosis, and it relies on the need to engage
citizens to take greater responsibility for their health. In fact, despite
the tremendous increase in life expectancy, the latest Eurostat data
reports that the average number of years of life lived with some
disability in the EU is around 18. Given the potential for effective
preventive efforts in postponing the onset of disabilities and reduc-
ing healthcare costs, the expectation is that the current ‘one size fit
all’ approaches in prevention take advantage of the new technologies
in healthcare in order to be targeted at those who need more. The
expectations to realize such personalized approach in preventive
healthcare are not new. Already in 2008 an editorial reported that
‘if preventive care could be provided only to those who are going to
get the illness, it would be more effective and cost-effective’.3 More
than 10 years later, however, we are still struggling to collect high
quality evidences on the efficacy, effectiveness and efficiency of per-
sonalized approaches in prevention, ideally in the context of broad
Health Technology Assessment evaluations.4 Additionally, we need
to engage public health professionals. In 2018, some scientists
argued that whereas public health starts with populations, the
word ‘precision’ or personalized implies a concern only with indi-
viduals.5 Although a later editorial from Lancet replied that ‘preci-
sion public health . . . should not be feared. It should be embraced’,6
the more traditional public health professionals are still stocked with
prejudices that are grounded to some extent. In fact, while Big Data
in healthcare already demonstrated their power in providing accur-
ate information for decision makers to target more precise inter-
ventions at populations in the greatest need, when we talk about
incorporating individual -omic profiling in preventive strategies, the
situation is still uncertain. In theory, the -omic profiling might be
considered a useful component of health management since birth,
but the extent to which it really represents an added value in terms
of improved outcomes and quality of life needs additional evidences.
Let us consider the polygenic risk score (PRS), which is a number
based on variation in multiple genetic loci and their associated
weights that can be used to predict a certain diseases’ risk. The
use of PRS in health subjects is an important area of development
for public health and warrants close attention, but there is still a
good deal to learn about how to maximize benefits for population
health. In principle, estimating the individual susceptibility of a
common adult-onset conditions, is central to clinical decision-
making, however, risk prediction does not necessarily implies ef-
fective prevention and improved outcomes. Although evidences
are accumulating from large retrospective cohort studies across
Europe on the ability of PRS to accurately stratify population in
subgroups that can differentially benefit from target primary
and secondary preventive interventions based on drugs or life-
styles, we still need large prospective studies that demonstrate
and quantify the impact of PRS at population level in terms of
disease prevention.
Last but not least, all the stakeholders should be engaged in the
discussion to properly implement precision public health. We need
all professionals in healthcare being literate on the potential and
challenges of the use of current technologies in healthcare, and we
need an increased health literacy at the population level. Premature
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translation of innovations in prevention can do more harm than
benefit, if people are convinced that extensive self-monitoring
with devices is useful, or undergoing a Direct to consumer
Genetic test will save their lives. In this sense the advocacy of
informed public health professionals is a key issue. In conclusion,
scientific innovation offers amazing opportunity: it is our respon-
sibility as scientists to support policy makers in dissecting the
hypes from the real value-based interventions. It is not easy in
such a complex scenario, but it is even more relevant for those
working in public health.
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Kepler Universitätsklinikum, Krankenhausstrasse 26-30, 4020 Linz, Austria, Tel: þ43576808422001, Fax:
þ43576808422004, e-mail: wolfgang.hoegler@jku.at
.........................................................................................................................................
Around the world, populations struggle to achieve healthy levelsof vitamin D1 and even in Europe, an estimated 13% of the
population is deficient, defined as serum 25OH vitamin D levels
below 30 nmol/L.1 Geographical, cultural and ethnic risk factors
such as living in high-latitude countries with limited UVB light,
sun-avoidance behaviour and specifically dark-skin pigmentation
predispose to vitamin D deficiency and its complications.2
Hypocalcaemic seizures, tetany, cardiomyopathy, rickets and osteo-
malacia with associated muscular hypotonia and pain occur specif-
ically in ethnic groups that are vitamin D deficient and/or consume
little dietary calcium.2
A combination of socioeconomic factors puts migrant and ethnic
populations in high latitude, western countries at a disproportion-
ally high risk for severe vitamin D deficiency, with growing children
being at greatest risk of complications.2 In these settings, vitamin D
deficiency can be seen as an indicator of health care inequalities
between ethnic groups. In Australia, Sweden, Norway and the UK,
rickets is almost exclusively reported in dark-skinned children,
which signposts public health strategies that continually miss the
target.3 In Britain during the industrial revolution, rickets became
known as the English disease before food fortification eradicated it.
Once this approach was abandoned, the disease made a rapid come-
back. In the last decades, millions of dark-skinned migrants from
mainly Commonwealth countries have shifted the UK population’s
demographics. However, instead of re-designing its public health
measures to ensure that rickets was once again eradicated, the UK
government continues in policy apathy and stigmatized the disease
as ‘Asian rickets’.3
Protecting entire populations, or just specific high-risk groups,
from micronutrient deficiencies is a challenge, and supplementation
and fortification are the options. There is evidence that supplemen-
tation programmes are inefficient in tackling vitamin D deficiency in
some European countries such as the UK, mainly due to poor policy
implementation, access, monitoring and adherence. For supple-
ments to be effective, people need to somehow become aware that
they need them, find where to get them, purchase them and finally
take them religiously according to the appropriate schedule. Often
those who need supplements the most likely fall through. In con-
trast, food fortification overcomes many of these obstacles by reach-
ing all individuals, with the only requirement that they regularly
consume the fortified food. Staple foods such as bread, oil and flour
are therefore good candidate vehicles to reach entire populations.
A recent economic evaluation found that fortifying wheat flour
with vitamin D in England and Wales would prevent 10 million new
cases and save the National Health Services’ budget £65 million.4
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